A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Phase 2 Terminated 155 enrolled Human Genome Sciences Inc.

NaSingle-groupOpen-labelTreatment

Summary

This is a continuation trial of LymphoStat-B™ to evaluate the long-term safety in subjects with Rheumatoid Arthritis that completed study LBRA01 and benefitted from treatment.

Timeline

Start: 2005-01
Primary completion: 2009-11
Completion: 2009-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Belimumab	Monoclonal antibody	10 mg/kg	Intravenous

A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Summary

Timeline

Drugs

Indications